AI
Thursday, September 20, 2012 7:34:08 AM
DYAX. Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
